BANK OF AMERICA CORP /DE/ - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 90 filers reported holding STOKE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$226,779
+4.8%
57,558
+182.9%
0.00%
Q2 2023$216,289
+1.7%
20,347
-20.3%
0.00%
Q1 2023$212,681
-7.9%
25,532
+2.1%
0.00%
Q4 2022$230,861
+207.8%
25,012
+327.5%
0.00%
Q3 2022$75,000
-65.1%
5,851
-64.2%
0.00%
Q2 2022$215,000
+18.1%
16,322
+89.1%
0.00%
Q1 2022$182,000
-85.9%
8,632
-83.9%
0.00%
Q4 2021$1,289,000
+502.3%
53,742
+540.0%
0.00%
Q3 2021$214,000
-48.4%
8,397
-31.9%
0.00%
Q2 2021$415,000
-16.5%
12,323
-3.8%
0.00%
Q1 2021$497,000
+126.9%
12,811
+263.0%
0.00%
Q4 2020$219,000
+63.4%
3,529
-11.4%
0.00%
Q3 2020$134,000
-38.5%
3,983
-56.5%
0.00%
Q2 2020$218,000
+62.7%
9,156
+56.5%
0.00%
Q1 2020$134,000
+31.4%
5,849
+61.9%
0.00%
Q4 2019$102,000
+29.1%
3,613
-2.7%
0.00%
Q3 2019$79,0003,7140.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 16,786,713$562,187,00075.80%
RTW INVESTMENTS, LP 3,544,248$118,697,0002.86%
Cormorant Asset Management, LP 1,537,807$51,501,0001.98%
Redmile Group, LLC 2,549,506$85,383,0001.57%
Birchview Capital, LP 40,000$1,340,0000.45%
HighVista Strategies LLC 17,082$572,0000.42%
Perceptive Advisors 671,978$22,505,0000.33%
GILDER GAGNON HOWE & CO LLC 1,490,153$49,905,0000.31%
Artal Group S.A. 270,750$9,067,0000.22%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 323$11,0000.20%
View complete list of STOKE THERAPEUTICS INC shareholders